The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Etentamig in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with prior exposure to B-cell maturation antigen (BCMA)–targeted therapy.
 
Saurabh Chhabra
Honoraria - Ascentage Pharma; Bristol-Myers Squibb/Roche; Legend Biotech; Pfizer; Sanofi; SOBI
Research Funding - Abbvie (Inst); AstraZeneca (Inst); C4 Therapeutics (Inst); CARsgen Therapeutics (Inst); Cullinan Oncology (Inst); Cynata Therapeutics (Inst); Janssen (Inst)
 
Emma Searle
Honoraria - AbbVie; BeiGene; Bristol-Myers Squibb; Janssen; Nurix
Consulting or Advisory Role - Bristol-Myers Squibb; DarkBlue Therapeutics; Sanofi; Shattuck Labs
Speakers' Bureau - AbbVie; Janssen; Jazz Pharmaceuticals; Pfizer
 
Rakesh Popat
Honoraria - Abbvie; BMS; Celgene; GlaxoSmithKline; Johnson & Johnson/Janssen; Pfizer
Consulting or Advisory Role - Galapagos NV; GlaxoSmithKline; Janssen; Regeneron; Roche; Sanofi
Speakers' Bureau - Pfizer
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
 
Hila Magen
No Relationships to Disclose
 
Moshe Gatt
No Relationships to Disclose
 
Irit Avivi
Consulting or Advisory Role - AbbVie; AstraZeneca; Epizyme; Janssen; MSD; Novartis; Roche
Speakers' Bureau - AbbVie; Gilead Sciences; Janssen; Novartis
 
Muhamed Baljevic
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb/Celgene; Cardinal Health; Genzyme; Janssen Research & Development; Karyopharm Therapeutics
Speakers' Bureau - Curio Science; MJH Life Sciences; National Comprehensive Cancer Network; Targeted Oncology
Other Relationship - PAREXEL
 
Neha Korde
Honoraria - Cancer Network; Clinical Care Operations; Intellisphere; OncLive; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - AbbVie; Amgen; Epizyme; Janssen
Travel, Accommodations, Expenses - DAVA Oncology
 
Cesar Rodriguez Valdes
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Speakers' Bureau - Johnson & Johnson/Janssen
 
Eben Lichtman
Consulting or Advisory Role - Abbvie; Lilly (I); Novartis (I); UCB (I)
Research Funding - Abbvie (Inst); Bristol Myers Squibb Foundation (Inst); GlaxoSmithKline (Inst); Pfizer (I); Poseida (Inst); Sanofi (Inst); sonoma pharmaceuticals (I)
 
Cyrille Touzeau
Honoraria - AbbVie; Bristol Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Pfizer; Sanofi
Consulting or Advisory Role - AbbVie; Bristol Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Pfizer; Sanofi
Research Funding - Sanofi (Inst)
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Kite/Gilead; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Kite/Gilead; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Anders Svensson
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Thomas Doerr
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Jovian Yu
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Xin (Shane) Li (Lee)
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Aarif Ahsan
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Tanya Rosenberg
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Chetasi Talati
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer